Congenital dyserythropoietic anemia type I

Congenital dyserythropoietic anemia type I (CDA I) is a disorder of blood cell production, particularly of the production of erythroblasts, which are the precursors of the red blood cells (RBCs).[1]

Congenital dyserythropoietic anemia type I
Classification and external resources
Specialty hematology
ICD-10 D64.4
ICD-9-CM 285.8

Genetics

CDA type I is transmitted by both parents autosomal recessively and usually results from mutations in the CDAN1 gene. Little is known about the function of this gene, and it is unclear how mutations cause the characteristic features of CDA type I. Some people with this condition do not have identified mutations in the CDAN1 gene, leading researchers to believe that mutations in at least one other gene can also cause this form of the disorder.[2]

Version Type OMIM Gene Locus
Ia CDAN1A 224120 CDAN1 15q15
Ib CDAN1B 615631 C15ORF41 15q14

Description

CDA type I is characterized by moderate to severe anemia. It is usually diagnosed in childhood or adolescence, although in some cases, the condition can be detected before birth. Many affected individuals have yellowing of the skin and eyes (jaundice) and an enlarged liver and spleen (hepatosplenomegaly). This condition also causes the body to absorb too much iron, which builds up and can damage tissues and organs. In particular, iron overload can lead to an abnormal heart rhythm (arrhythmia), congestive heart failure, diabetes, and chronic liver disease (cirrhosis). Rarely, people with CDA type I are born with skeletal abnormalities, most often involving the fingers and/or toes.[2]

Treatment

Treatment consists of frequent blood transfusions and chelation therapy. Potential cures include bone marrow transplantation and gene therapy.

See also

References

  1. ↑ Congenital dyserythropoietic anaemia type I - Enerca (European Network for Rare and Congenital Anaemias) website
  2. 1 2 congenital dyserythropoietic anemia - Genetics Home Reference
This article is issued from Wikipedia - version of the 9/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.